Correlation Between P3 Health and Novo Integrated
Can any of the company-specific risk be diversified away by investing in both P3 Health and Novo Integrated at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining P3 Health and Novo Integrated into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between P3 Health Partners and Novo Integrated Sciences, you can compare the effects of market volatilities on P3 Health and Novo Integrated and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in P3 Health with a short position of Novo Integrated. Check out your portfolio center. Please also check ongoing floating volatility patterns of P3 Health and Novo Integrated.
Diversification Opportunities for P3 Health and Novo Integrated
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between PIII and Novo is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding P3 Health Partners and Novo Integrated Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Integrated Sciences and P3 Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on P3 Health Partners are associated (or correlated) with Novo Integrated. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Integrated Sciences has no effect on the direction of P3 Health i.e., P3 Health and Novo Integrated go up and down completely randomly.
Pair Corralation between P3 Health and Novo Integrated
Given the investment horizon of 90 days P3 Health Partners is expected to under-perform the Novo Integrated. But the stock apears to be less risky and, when comparing its historical volatility, P3 Health Partners is 1.88 times less risky than Novo Integrated. The stock trades about -0.01 of its potential returns per unit of risk. The Novo Integrated Sciences is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 110.00 in Novo Integrated Sciences on November 2, 2024 and sell it today you would lose (105.59) from holding Novo Integrated Sciences or give up 95.99% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 89.47% |
| Values | Daily Returns |
P3 Health Partners vs. Novo Integrated Sciences
Performance |
| Timeline |
| P3 Health Partners |
| Novo Integrated Sciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
P3 Health and Novo Integrated Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with P3 Health and Novo Integrated
The main advantage of trading using opposite P3 Health and Novo Integrated positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if P3 Health position performs unexpectedly, Novo Integrated can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Integrated will offset losses from the drop in Novo Integrated's long position.| P3 Health vs. Sonida Senior Living | P3 Health vs. Acadia Healthcare | P3 Health vs. CryoCell International | P3 Health vs. Community Health Systems |
| Novo Integrated vs. Aveanna Healthcare Holdings | Novo Integrated vs. P3 Health Partners | Novo Integrated vs. IMAC Holdings | Novo Integrated vs. Oncology Institute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |